Abstract:The final, formatted version of the article will be published soon. You have multiple emails registered with Frontiers: Please enter your email address: If you already have an account, please login You don't have a Frontiers account ? You can register here Tuberculosis (TB) has once again become the world's leading cause of death from a single infectious agent following three years of COVID19 pandemic [1]. Accounting for 1.25 million deaths, TB remains the leading cause of death among people living with human immunodeficiency virus (HIV) (PLWH) [1], and was responsible for approximately twice as many deaths as HIV/ acquired immunodeficiency syndrome (AIDS) alone [2]. The immune responses to monoinfection with the causative agent, Mycobacterium tuberculosis (Mtb), are distinct from those observed in individuals infected with HIV or in those who are coinfected with both pathogens [3,4]. Pulmonary TB represents the most common manifestation of the active disease, characterized by the presence of classical lung caseous/necrotic granuloma lesions, accompanied by exudation. The disease typically progresses after two years of a latent TB infection, an asymptomatic immune activated phase following the initial primary infection [1,5].The immune cells involved in the responses to Mtb infection include innate myeloid cells, such as macrophages and neutrophils, and adaptive lymphocytes including T and B cells. If the equilibrium between innate and adaptive immune cells, which is essential for maintaining an appropriate proinflammatory/anti-inflammatory cytokine milieu, is disrupted, Mtb may disseminate from lungs to other organs, leading to the development of extrapulmonary TB. An appropriate adaptive response is necessary to facilitate the homing of effector T-lymphocytes, which is essential for the full organization and sustainability of the granuloma. This means that mycobacteria-containing macrophages are situated at the center, encircled by a rim of newly arrived lymphocytes that form a solid granuloma and exhibit a highly organized framework with high vascularization [6]. A failure to maintain this dynamic will result in structural disruption, thereby facilitating the migration of infected macrophages to other organs [7].It has long been established that functional impairments in both the innate and adaptive immune responses in PLWH contribute to an increased risk of TB disease in this population [8]. As a consequence of the immunodeficiency status generated by low CD4 + T-cell counts, this population is also more prone to the development of independent or concurrent extrapulmonary TB. Consequently, the pathophysiology of Mtb infection differs in HIV-positive individuals, and even more so in those who have progressed to severe AIDS phase. The mechanisms by which alterations in Mtb-specific T-cell responses may impede the early clearance of Mtb or sustained control of LTBI in PLWH remain poorly understood. PLWH appear to an altered cytokine profile in response to Mtb, which includes impairments in type I helper T-cell responses (Th1), a reduction in the activity of Th17 cells and regulatory T-cells, and an increase in immunosuppressive cytokines [8,9]. Furthermore, the incidence of smear-negative and subclinical TB is also higher among co-infected patients. This results in a reduction of the sensitivity of screening tests based on sputum examination.The identification of immune-related complexes or molecules that can be defined as diagnostic markers for Mtb in PLWH may facilitate the development of new diagnostic tools and the exploration of new therapeutic approaches. In comparison to monoinfections with either HIV or Mtb, during coinfection the immune cells subsets and functions in the peripheral blood, as well as their redistribution in local lesions, may undergo dramatic alterations. Additionally, deviations in the metabolism and the divergence of the ubiquitin machinery may also be observed. Altogether, the aforementioned factors represent the focus of this research topic.In this issue, an original research article by Yandrapally et al. (https://doi.org/10.3389/fimmu.2023.1276817) shows that the Mtb-secreted transcription regulator EspR contributes to a syndemic interaction during coinfection with HIV. It is hypothesized that binding to the putative cognate motif on the promoter region of the host IL-4 gene, leads to IL-4 gene expression, causing high IL-4 titers that induce a Th2-type microenvironment. Consequently, this results in a shift towards a Th2-type response, which facilitates macrophage polarization to a M2 anti-inflammatory and metabolic status that favours Mtb persistence. Chronic infection by HIV tends to induce a shift in the viral population from the R5 to the X4 phenotype, which is accompanied by an increasing in the expression of the CXCR4 receptor. This suggests that the mycobacteria-induced selection of X4 -Abstract Truncated-

Concomitant parasite infections influence tuberculosis immunopathology and favor rapid sputum conversion of pulmonary tuberculosis patients

Intestinal Protozoa, Helminth Infection, and Associated Factors among Tuberculosis Patients and Nontuberculosis Persons in Bobo-Dioulasso City, Burkina Faso

Mixed Th1 and Th2 Mycobacterium tuberculosis-specific CD4 T cell responses in patients with active pulmonary tuberculosis from Tanzania

Influence of Strongyloides stercoralis Coinfection on the Presentation, Pathogenesis, and Outcome of Tuberculous Meningitis

Immunopathology in human pulmonary tuberculosis: Inflammatory changes in the plasma milieu and impaired host immune cell functions

Decreased IL-17 during treatment of sputum smear-positive pulmonary tuberculosis due to increased regulatory T cells and IL-10

T cells exhaustion, inflammatory and cellular activity markers in PBMCs predict treatment outcome in pulmonary tuberculosis patients

Anaerobe-enriched gut microbiota predicts pro-inflammatory responses in pulmonary tuberculosis

Differences in PPD- and mitogen-induced T-cell activation marker expression characterize immunopathology in acute tuberculosis patients

Monocyte transcriptome signatures of inflammation and enhanced neutrophil recruitment characterize immunopathology in the blood of tuberculosis patients

Human-immunodeficiency virus infection associated with the impaired Th1 and pro-inflammatory cytokine response in latent tuberculosis-infected individuals: A comparative cross-sectional study

Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosis

Editorial: Immune responses to MTB infection in people living with HIV

Patient Characteristics Associated with Concurrent Klebsiella pneumoniae Infection and Severe Pulmonary Tuberculosis

Host and pathogen factors that influence variability of Mycobacterium tuberculosis lipid body content in sputum from patients with tuberculosis: an observational study

Pre-existing Simian Immunodeficiency Virus Infection Increases Expression of T Cell Markers Associated with Activation during Early Mycobacterium tuberculosis Coinfection and Impairs TNF Responses in Granulomas

The Dynamic Changes of Tuberculosis Related Cytokines During Disease Progression

Phenotype and function of peripheral blood γδ T cells in HIV infection with tuberculosis

Paired Analysis of Host and Pathogen Genomes Identifies Determinants of Human Tuberculosis

Tuberculosis: Current state of knowledge: An Epilogue

Mycobacterium tuberculosis and human immunodeficiency virus co-infection and associated variables among presumptive pulmonary tuberculosis patients in Ethiopia; a health institution based cross-sectional study